Clinical Trials Logo

Filter by:
NCT ID: NCT00667758 Completed - Clinical trials for Rheumatoid Arthritis

Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis

AGRA
Start date: May 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the safety and efficacy of gonadotropin-releasing hormone (GnRH) antagonist therapy versus placebo in patients with moderate to severe rheumatoid arthritis.

NCT ID: NCT00667043 Completed - Hypothermia Clinical Trials

Remifentanil and Propofol Versus Fentanyl and Midazolam for Sedation During Therapeutic Hypothermia. A Randomised, Controlled Trial

Cool Sedation
Start date: April 2008
Phase: Phase 4
Study type: Interventional

The aim of this study is to increase knowledge about drug properties and effects during therapeutic hypothermia. The primary end point of this study is the time from termination of sedation to extubation in patients treated with therapeutic hypothermia, after treatment with the combination remifentanil and propofol versus that of fentanyl and midazolam.

NCT ID: NCT00666458 Completed - Type 2 Diabetes Clinical Trials

18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)

Start date: April 2008
Phase: Phase 3
Study type: Interventional

Saxagliptin is a new investigational medication being developed for treatment of type 2 diabetes. This study is designed to assess the efficacy and tolerability of saxagliptin in addition to metformin and compare to sitagliptin in addition with metformin.

NCT ID: NCT00666094 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Randomized Controlled Trial of Exercise Training Among Men With Type 2-diabetes

Start date: August 2008
Phase: N/A
Study type: Interventional

To test the hypothesis that there is no difference in change in HbA1C among men with type 2-diabetes after an exercise intervention with strength versus endurance training.

NCT ID: NCT00665496 Completed - Clinical trials for Erectile Dysfunction

A Study to Investigate the Time to Onset of Action of 10 mg and 20 mg of Vardenafil Compared to Placebo in Males With Erectile Dysfunction

Start date: June 2003
Phase: Phase 3
Study type: Interventional

This purpose of the study was to evaluate the earliest time to onset of action in adults with erectile dysfunction (often called impotence). In this study vardenafil has been compared to placebo. Patients were asked to fill in questionnaires and a diary in which they filled in details about attempts at sexual activity during study period. Patients received also a stopwatch to record the time of onset of erection. Stopwatch should be started immediately prior to initiating sexual activity and stopped when an erection perceived to be adequate for penetration was obtained.

NCT ID: NCT00664976 Completed - Bipolar Disorder Clinical Trials

Treatment Resistant Depression in Bipolar Disorder - A Randomized Controlled Trial of Electroconvulsive Therapy

Start date: April 2008
Phase: N/A
Study type: Interventional

This project is a randomized controlled trial of electroconvulsive therapy (ECT) compared to treatment as usual (TAU) in the treatment of treatment resistant depression (TRD) in bipolar disorder. The purpose of the trial is to document the effect size, relative effect size and adverse effects of ECT in this condition. A specific purpose is to gain more knowledge about the effect on cognitive function.

NCT ID: NCT00662831 Completed - Diabetic Foot Ulcer Clinical Trials

Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients

FEENICS
Start date: April 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the study isto see the effect of Fragmin on the healing of diabetic foot ulcers by determining the number of subjects with ≥50% reduction in ulcer surface area including intact skin healing.

NCT ID: NCT00662285 Enrolling by invitation - Iron Deficiency Clinical Trials

Description of Iron Status in Blood Donors

Start date: April 2008
Phase: N/A
Study type: Interventional

Description of the effect of standard iron supplement on iron status in blood donors Hypothesis: For each person in each group (group a "without iron supplement" or group b "with iron supplement") individual biological variation in reticulocytes, tested day 1 and day 8 will be described. Groups a and b will be compared on iron status from day 1 and day 8. - H1 null: There is no significant intraindividual difference in reticstatus at day 1 and at day 8, in group a. - H2 null: There is no significant intraindividual difference in reticstatus at day 1 and at day 8, in group b - H3 null: There is no significant difference in iron status for the two groups, a and b, at day 1 and at day 8.

NCT ID: NCT00660582 Completed - Clinical trials for Metastatic Colorectal Cancer

FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor

Start date: April 2008
Phase: Phase 2
Study type: Interventional

The Nordic FLOX-regime consists of a combination of bolus 5-FU, leukovorin and oxaliplatin (Eloxatin®). Cetuximab (Erbitux®) is an antibody against the epidermal growth factor receptor (EGFR). The combination of FLOX and weekly Erbitux has been investigated in the Nordic VII study where 571 patients were randomized to FLOX (regime A) or FLOX + Erbitux (regime B or C). Effect-data has not yet been published but the combination is well tolerated, and other studies have shown that Erbitux administered with chemotherapy seem to be more efficient than chemotherapy alone. The main purpose with this study is to investigate the effect of FLOX and Erbitux given every second week as first line treatment for patients with metastatic colorectal cancer and K-RAS wildtype tumor. The latest accessible data regarding treatment towards EGFR and K-RAS mutations shows that patients with K-RAS wildtype responds better to treatment than patients with K-RAS mutations.

NCT ID: NCT00660491 Completed - Healthy Subjects Clinical Trials

Endothelial Dysfunction Induced by Postprandial Lipemia

Start date: January 2008
Phase: Phase 2
Study type: Interventional

Postprandial lipemia and exercise oppose each other in terms of cardiovascular risk, however the mechanism of their interaction is not well understood. Therefore we want to study vascular function, as assessed by brachial artery (BA) flow mediated dilation (FMD), in healthy men before and after a high fat meal (HFM) preceded (16-18 hrs) by rest, a single bout of continuous moderate intensity exercise (CME), and high intensity interval exercise (HIIE).